Posted in Newsletters
Estimated read time 8 min read

New York Times sues Perplexity AI for ‘illegal’ copying of content

In Today’s News

👀 This simple trade happens 3-5x’s a week, Options expert shares his strategy. [sponsor]

New York Times sues Perplexity AI for ‘illegal’ copying of content

The startup has become a target of multiple legal disputes and faces similar accusations from a number of publishers as it tries to aggressively build market share in a hyper-competitive market for generative AI tools. The Times said that Perplexity AI is also violating its trademarks under the Lanham Act, cl …

Read More »

A Revolutionary Breakthrough in the Fight Against Cancer – A Unique Opportunity Awaits! [sponsor]
 This innovative biotech’s proprietary platform has the potential to redefine cancer therapy—enhancing efficacy while minimizing side effects. The evidence is compelling, the moment is crucial, and industry giants are taking note. Seize this opportunity before Wall Street reacts!

Fed’s internal split puts spotlight on Powell’s rate guidance, dissents

NEW YORK, Dec 5 (Reuters) – The Federal Reserve meeting next week is expected to be one of its most contentious in years, and investors are focused on how divided policymakers are over an expected interest-rate cut and what Chair Jerome Powell signals about the path ahead.Five of the 12 voting members of the …

Read More »

Did You Miss Out on $0.81? RAD Intel Now Available at Just $0.85/Share! [sponsor]
 RAD Intel’s valuation has skyrocketed by 4,900%, attracting Fortune 1000 clients and raising over $60M. Now, shares are priced at $0.85 with limited availability for new investors. Seize this opportunity while it lasts! Secure Your $0.85 Shares Before They’re Gone!

Featured Article

Netflix to buy Warner Bros Discovery’s studios, streaming unit for $72 billion

Dec 5 (Reuters) – Netflix on Friday agreed to buy Warner Bros Discovery’s TV, film studios and streaming division for $72 billion, a deal that would hand control of one of Hollywood’s most prized and oldest assets to the streaming pioneer.The agreement follows a weeks-long bidding war in which Netflix offered …

Read More »

Is Your Investment Portfolio at Risk? [sponsor]
 If you haven’t included any of the Next Magnificent Seven stocks in your holdings, you’re potentially missing out. The original Magnificent Seven transformed a $7,000 stake into an astonishing $1.18 million. These seven AI stocks have the potential to replicate that success in just 6 years (not 20). Now, the visionary who predicted Nvidia’s rise in 2005 is ready to share insights on all seven stocks at no cost to you! Unlock the Details Now Before the Window Closes!

Other Headlines

Meta strikes multiple AI deals with news publishers

The tie-ups will allow the Facebook-parent to provide “real-time” news and updates through its artificial intelligence chatbot by linking to articles and websites from the publishers. The move comes as the social media giant looks to attract more users to its AI services amid increasing competition in the mar …

Read More »

Is Your Financial Institution Prepared for S.1582? [sponsor]
 A little-known legislation (S.1582) was recently enacted by President Trump. This law empowers a select group of entities to create a novel form of government-sanctioned currency. The Treasury Department cautions that this transformation could siphon off $6.6 trillion from conventional banks, while Forbes labels it a $10 trillion opportunity. Savvy investors making informed decisions before October 16 could potentially amplify their returns by up to 40 times by 2032… However, those who neglect to act may find themselves caught off guard by this monumental shift in the U.S. dollar landscape. Discover the full story here.

Apple sends new round of cyber threat notifications to users in 84 countries

Apple is one of several tech companies that regularly issue warnings to users when it determines they may have been targeted by state-backed hackers. Apple’s statement, which said the warnings were issued on December 2,  carried few further details about the alleged surveillance and did not address ques …

Read More »

Revealed: Apple’s Groundbreaking “Project Mulberry” Set to Disrupt $9 Trillion Sector [sponsor]
 In a stunning disclosure, Bloomberg has shed light on Apple’s top-secret “Project Mulberry,” a monumental 13-year initiative that Tim Cook proclaims as “Apple’s most significant gift to humanity.” Within the depths of their supply chain lies a lesser-known firm crafting a revolutionary chip that is smaller than a grain of sand. With BlackRock holding 2.8 million shares and Goldman Sachs increasing its position by an impressive 340%, this is a moment you cannot afford to overlook—this $30 stock is poised for a remarkable ascent. Discover the complete story from tech analyst Ian King now…

Bessent under discussion to also lead US National Economic Council, Bloomberg News reports

Bessent would lead the White House’s National Economic Council in addition to his current role, in the event Kevin Hassett is picked as the next Federal Reserve chair, the report added. Reuters could not immediately verify the report. (Reporting by Ananya Palyekar in Bengaluru; Editing by Chris Reese) …

Read More »

Safeguard Your Bank Account in 4 Easy Steps [sponsor]
 The United States government made a sweeping change to bank accounts nationwide. It gave them unheard-of powers to control your bank account. They can now closely track every transaction. They could even freeze it. Unless you protect yourself today. Fortunately, there are 4 simple steps you can take to safeguard your savings. Discover these 4 simple steps here.

Ford recalls nearly 109,000 vehicles, NHTSA says

   The recall covers certain 2020–2022 Escape and 2025 Escape models. Dealers will inspect and reinstall or replace any missing liftgate hinge covers as needed, free of charge, the regulator said. Separately, Ford has also recalled nearly 12,000 Lincoln MKT 2016-2019 vehicles as the driver and …

Read More »

Breakthrough Biotech: A Game-Changer in Cancer Treatment After 50 Years of Chemo [sponsor]
 For over five decades, conventional chemotherapy has dominated cancer treatment, often with harsh side effects. This pioneering biotech company is poised to revolutionize cancer care with its novel, non-toxic approach. Early data highlights their potential to deliver targeted treatments without the detrimental effects, making this a compelling opportunity for discerning investors. Discover the complete opportunity and the innovative company behind it.

Jumped the gun, says Morgan Stanley; reverses Dec Fed rate call to 25bps cut

All three brokerages previously expected the Fed to hold rates steady in December.Softer U.S. economic data released late November and dovish comments from key Fed officials, including from New York Fed President and the Federal Open Market Committee Vice Chair John Williams, Fed Governor Christopher Waller a …

Read More »

The “Super Chip” Driving 99% of ____ [sponsor]
 It’s neither NVIDIA nor Intel. Yet, this underrated stock’s designs already empower 99% of a vital technology. Now, it is venturing into AI chips for data centers, autonomous vehicles, and robotics. Major Tech companies are racing to license its architecture. Governments are eager to secure it. And Wall Street has yet to catch on. Discover the complete report here.

Disclaimer: This is a paid advertisement for educational purposes only and does not constitute financial advice. Investing involves risk and may not be suitable for all individuals. Past performance does not guarantee future results.
Trading Cheat Sheet is owned and operated by PROTRADING RESEARCH LLC. We are not licensed financial advisors. Always consult with a certified financial professional before making investment decisions.

IMPORTANT NOTICE AND DISCLAIMER
Pro Trading Research, LLC (“PTR”), the owner of this website (the “Website”), cannot guarantee the accuracy or completeness of the information contained in any article, email, newsletter, or other publication posted on or viewed in connection with this website (the “Publications”). The author or authors of those Publications are solely responsible for their contents. PTR has not done any research or due diligence into the markets, industries, or companies which may appear or be mentioned in the Publications. PTR will NOT be liable for any loss or damage caused by a reader’s reliance on information posted on the Website or contained in the Publications.

FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE.
This Website and the Publications are for educational and informational purposes only. This Website and the Publications do not purport to be a complete analysis of any company’s financial position. This Website, the Publications or any statements made in the Publications are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. This Website or the statements made in the Publications should NOT be relied upon for purposes of transacting in any securities posted on the Website or mentioned in the Publications, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security posted on this Website or mentioned in any Publications.b>

SUBSTANTIAL RISK IN INVESTMENT.
Any individual who chooses to invest in any securities including those mentioned in the Publications should do so with caution. Investing or transacting in securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers bear responsibility for their own investment research and decisions and should review all investment decisions with a licensed or registered investment professional.

NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER
Neither PTR nor any of its respective owners or employees are registered or licensed as a securities broker-dealer, broker, an investment advisor, or an investment advisor representative with the U.S. Securities and Exchange Commission (SEC), any state securities regulatory authority, or any self-regulatory organization.

Policies and contact:  Disclaimer  |  Privacy  |  Terms

Trading Cheat Sheet
203 N La Salle Street, Suite 2100 | Chicago, IL 60601

unsubscribe

You May Also Like

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Recent Posts

Categories